These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7285030)

  • 21. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B
    Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic effects of prazosin in heart failure].
    Bassand JP; Becque O; Vial Y; Berthout P; Maurat JP
    Nouv Presse Med; 1979 Nov; 8(44):3663. PubMed ID: 534219
    [No Abstract]   [Full Text] [Related]  

  • 24. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prazosin in the treatment of chronic resistant heart failure].
    Kleinman Y; Tzivoni D
    Harefuah; 1981 Apr; 100(8):398-401. PubMed ID: 7274816
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy].
    Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226
    [No Abstract]   [Full Text] [Related]  

  • 28. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term treatment of cardiac insufficiency with prazosin].
    Grolleau R; Errera J; Gallay P
    Ann Cardiol Angeiol (Paris); 1984; 33(4):247-51. PubMed ID: 6465817
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
    Packer M; Meller J; Gorlin R; Herman MV
    Circulation; 1979 Mar; 59(3):531-9. PubMed ID: 761333
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Haemodynamic effects and plasma concentrations of prazosin in chronic heart failure (author's transl)].
    Pornin M; Decourt S; Sellier P; Guermonprez JL; Ourbak P; Maurice P; Flouvat B
    Therapie; 1981; 36(4):435-42. PubMed ID: 7292426
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled study of long-term prazosin in refractory heart failure.
    Lemke R; Trompler A; Kaltenbach M; Bussmann WD
    Eur Heart J; 1981 Jun; 2(3):211-6. PubMed ID: 7274282
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prazosin in heart insufficiency. Short-term hospital clinical trial].
    Sánchez Domińguez J; González Villa J; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Mar; 160(6):371-6. PubMed ID: 7255801
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of red rest and prazosin in congestive heart failure.
    Thaulow E; Ihlen H; Kjekshus J; Forfang K; Storstein O
    Acta Med Scand; 1982; 212(3):131-6. PubMed ID: 7148503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prazosin and congestive heart failure: short- and long-term therapy.
    Rouleau JL; Warnica JW; Burgess JH
    Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic effects and clinical observations on prazosin in treating chronic refractory congestive heart failure].
    Shen LH; Ku FS; Liu QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):244-7, 315. PubMed ID: 6544203
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
    Chatterjee K; Parmley WW
    J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.